Supplements for Eczema (Atopic Dermatitis): What t…

Atopic dermatitis (AD) is one of the most common chronic skin conditions, affecting roughly 15–20% of children and 1–10% of adults worldwide. It's driven by a complex interplay of skin barrier dysfunction, immune dysregulation (particularly Th2-skewed inflammation), and environmental triggers. Conventional treatment focuses on topical corticosteroids, calcineurin inhibitors, and increasingly biologic agents like dupilumab for moderate-to-severe disease.

Supplements don't replace these treatments. But several have enough clinical evidence to warrant serious consideration as adjuncts — particularly for people with mild-to-moderate AD who want to address underlying drivers rather than just suppress symptoms. Here's what the research actually shows, organized by the evidence quality for each.

Vitamin D: The Most Studied Supplement for AD

The link between vitamin D and atopic dermatitis is well-established epidemiologically: lower vitamin D levels correlate with higher AD prevalence and severity across multiple large observational studies. Multiple mechanisms make this biologically plausible:

Vitamin D stimulates expression of antimicrobial peptides (cathelicidin, beta-defensins) that protect skin from Staphylococcus aureus colonization — a major trigger for AD flares
Vitamin D regulates immune polarization, modulating Th2 dominance toward more balanced Th1/Th2 responses
Vitamin D promotes skin barrier protein expression, including filaggrin

Clinical trial evidence:

A 2014 randomized, double-blind, placebo-controlled trial published in Journal of Allergy and Clinical Immunology tested vitamin D3 at 1,000 IU/day for 1 year in 116 children with AD. Results showed significantly reduced SCORAD index scores and lower rates of flares compared to placebo.

A 2016 Iranian RCT using 1,600 IU/day for 60 days found statistically significant SCORAD improvement in adults with moderate AD.

A 2020 meta-analysis of 9 RCTs in Journal of Dermatological Treatment found that vitamin D supplementation significantly reduced SCORAD severity scores in AD patients compared to placebo.

Dosing recommendation:

Test baseline 25(OH)D level first
Target: 40–60 ng/mL serum vitamin D
Supplementation dose: 1,000–4,000 IU/day depending on baseline
Retest after 3 months

Evening Primrose Oil: GLA for Skin Barrier Lipids

Evening primrose oil (EPO) is rich in gamma-linolenic acid (GLA), an omega-6 fatty acid that serves as a direct precursor to prostaglandin E1 (PGE1) and anti-inflammatory eicosanoids. People with atopic dermatitis have documented deficiency in delta-6-desaturase activity — the enzyme that normally converts linoleic acid to GLA. This functional deficiency is thought to contribute to abnormal skin lipid composition.

Clinical evidence:

A 2003 systematic review of 26 trials of EPO and borage oil (another GLA source) in atopic dermatitis found modest but statistically significant improvements in overall symptom scores. The effect was more consistent for itch reduction than for objective severity measures.

A 2011 Japanese RCT testing 1,800mg GLA/day (from borage oil) for 12 weeks found significant improvements in SCORAD compared to placebo.

Dosing:

Evening primrose oil: 3,000–6,000mg/day (providing approximately 270–540mg GLA)
Borage oil: 1,000–2,000mg/day (higher GLA concentration: ~23%)
Allow 8–16 weeks for effect

Note: Several high-quality trials have failed to show benefit, and a 2013 Cochrane review was inconclusive. EPO/GLA is a reasonable adjunct with a plausible mechanism, but results are not guaranteed.

Probiotics: Lactobacillus rhamnosus GG and the Gut-Skin Axis

The microbiome-skin axis hypothesis proposes that dysbiosis (imbalanced gut microbiota) drives systemic immune skewing that manifests in atopic disease. Probiotic interventions have been studied extensively in AD — both for prevention and treatment.

Lactobacillus rhamnosus GG (LGG): This is the most clinically studied probiotic strain in atopic dermatitis. A landmark 2003 Isolauri et al. study found that LGG given to mothers during pregnancy and to infants reduced the cumulative incidence of atopic eczema by 50% at age 4 compared to placebo. Multiple follow-up studies have extended this finding.

For treatment (not prevention) of established AD, the evidence is more mixed. A 2016 meta-analysis in Journal of Allergy and Clinical Immunology analyzed 25 RCTs and found that probiotics significantly reduced SCORAD scores in children, with the best evidence for L. rhamnosus and Bifidobacterium lactis strains.

A 2022 Cochrane review was more cautious, noting heterogeneity across studies and recommending against broad probiotic recommendations, while acknowledging that specific strains in specific populations may benefit.

Dosing:

LGG (Lactobacillus rhamnosus GG): 1–10 billion CFU/day
Bifidobacterium lactis Bb-12: 1–5 billion CFU/day
Duration: minimum 8 weeks; many protocols run 3–6 months

The probiotic evidence is most robust for prevention in high-risk infants and children. For adult treatment, results are more variable.

Fish Oil (Omega-3 Fatty Acids)

EPA and DHA from fish oil compete with arachidonic acid (AA) for incorporation into cell membrane phospholipids. Replacing AA with EPA shifts the balance of eicosanoids produced during inflammation toward less inflammatory series-3 prostaglandins and series-5 leukotrienes — reducing the intensity of the inflammatory cascade in AD.

Clinical evidence:

The evidence for fish oil in AD is mixed. A 2012 Cochrane review of fish oil and EPO for eczema found insufficient evidence to recommend either. However, several individual RCTs have shown modest benefit:

A 2008 RCT found that high-dose EPA (1.8g/day) for 12 weeks improved overall severity, itch, and scaling in adults with moderate AD
A German study found omega-3 supplementation during pregnancy reduced rates of AD in offspring at 12 months

Dosing for AD:

EPA + DHA: 2,000–4,000mg/day total
EPA-predominant formulations may be preferable (EPA appears more anti-inflammatory in this context)
12-week minimum trial

Fish oil is broadly safe and has other health benefits, making it a low-downside addition to an AD management strategy even if the skin-specific benefit is modest.

Oral Ceramides for Barrier Repair

As covered in detail in our ceramides post, oral ceramides from wheat extract (Lipowheat) at 200mg/day have shown improvements in skin barrier function markers in both dry skin and an open-label AD study. Since AD is fundamentally a barrier disease, oral ceramides offer mechanistic logic: replenishing the lipid substrate that the compromised stratum corneum is deficient in.

The evidence base for AD specifically is early, but it's one of the few interventions targeting the primary defect (barrier lipid deficiency) rather than downstream immune consequences.

Zinc

Zinc deficiency is associated with skin barrier disruption, impaired wound healing, and inflammatory skin conditions including AD. Zinc supplementation in documented deficiency clearly helps. The evidence for zinc in non-deficient AD patients is weaker.

A small RCT found zinc sulfate (400mg/day) improved SCORAD in children with AD
A 2014 pilot study found zinc supplementation correlated with reduced Staphylococcus aureus colonization on AD skin

Practical approach: Test serum zinc levels; supplement if deficient (15–30mg zinc, as zinc picolinate or bisglycinate). Over-supplementing zinc without deficiency can impair copper absorption.

What to Stack and in What Order

For someone with mild-to-moderate atopic dermatitis looking to add supplements to their existing skincare regimen:

Priority 1 — Test and correct vitamin D. The evidence is strongest here and deficiency is common. Correct to 40–60 ng/mL.

Priority 2 — Add fish oil. 2–3g EPA+DHA/day. Broadly safe, anti-inflammatory, modest AD evidence.

Priority 3 — Trial LGG or a broad-spectrum probiotic. Best evidence in children and for flare prevention.

Priority 4 — Consider GLA from EPO or borage oil. 3,000–6,000mg EPO (or 1,000–2,000mg borage oil) if delta-6-desaturase pathway involvement seems likely (family history, early onset).

Priority 5 — Add oral ceramides. Lipowheat 200mg/day for barrier repair support.

The Bottom Line

No supplement cures atopic dermatitis. But vitamin D, fish oil, probiotics (particularly LGG), GLA from evening primrose oil, and oral ceramides each address distinct mechanistic aspects of AD: immune dysregulation, barrier lipid deficiency, gut-skin axis imbalance, and inflammatory eicosanoid production. Used alongside appropriate topical management, they offer a meaningful adjunctive strategy — particularly for people with mild-to-moderate AD who want to address root causes rather than indefinitely suppress symptoms.

Track your eczema flare frequency alongside your supplement routine to see which interventions are actually making a difference. Use Optimize free.

Supplements for Eczema (Atopic Dermatitis): What the Evidence Shows